 High-Throughput Screening Assays
"High-Throughput Screening Assays" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Rapid methods of measuring the effects of an agent in a biological or chemical assay. The assay usually involves some form of automation or a way to conduct multiple assays at the same time using sample arrays.
| Descriptor ID |
D057166
|
| MeSH Number(s) |
E05.916.680
|
| Concept/Terms |
High-Throughput Screening Assays- High-Throughput Screening Assays
- Assay, High-Throughput Screening
- High Throughput Screening Assays
- High-Throughput Screening Assay
- Screening Assay, High-Throughput
- Screening Assays, High-Throughput
High-Throughput Screening Methods- High-Throughput Screening Methods
- High Throughput Screening Methods
- High-Throughput Screening Method
- Methods, High-Throughput Screening
- Screening Method, High-Throughput
- Screening Methods, High-Throughput
High-Throughput Biological Assays- High-Throughput Biological Assays
- Assay, High-Throughput Biological
- Assays, High-Throughput Biological
- Biological Assay, High-Throughput
- Biological Assays, High-Throughput
- High Throughput Biological Assays
- High-Throughput Biological Assay
High-Throughput Chemical Assays- High-Throughput Chemical Assays
- Assay, High-Throughput Chemical
- Assays, High-Throughput Chemical
- Chemical Assay, High-Throughput
- Chemical Assays, High-Throughput
- High Throughput Chemical Assays
- High-Throughput Chemical Assay
|
Below are MeSH descriptors whose meaning is more general than "High-Throughput Screening Assays".
Below are MeSH descriptors whose meaning is more specific than "High-Throughput Screening Assays".
This graph shows the total number of publications written about "High-Throughput Screening Assays" by people in this website by year, and whether "High-Throughput Screening Assays" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 5 | 3 | 8 | | 2011 | 2 | 4 | 6 | | 2012 | 3 | 5 | 8 | | 2013 | 2 | 2 | 4 | | 2014 | 1 | 2 | 3 | | 2015 | 2 | 6 | 8 | | 2016 | 3 | 2 | 5 | | 2017 | 6 | 7 | 13 | | 2018 | 6 | 3 | 9 | | 2019 | 3 | 2 | 5 | | 2020 | 5 | 6 | 11 | | 2021 | 1 | 6 | 7 | | 2022 | 1 | 0 | 1 | | 2023 | 2 | 2 | 4 | | 2024 | 1 | 2 | 3 | | 2025 | 3 | 5 | 8 | | 2026 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "High-Throughput Screening Assays" by people in Profiles.
-
Hamilton AG, Thatte AS, Xu J, Luo Z, Safford HC, Swingle KL, Muscat-Rivera J, Kegel M, Han X, Joseph RA, Murray AM, Geisler HC, Whitaker RC, Xue L, Spektor R, Melamed JR, Weissman D, Mitchell MJ. High-Throughput In Vivo Screening Using Barcoded mRNA Identifies Lipid Nanoparticles With Extrahepatic Tropism for In Situ Immunoengineering. Adv Mater. 2026 Mar; 38(13):e14370.
-
Han EL, Kim D, Murray AM, Mrksich K, Hamilton AG, Tang S, Yoo S, Zhu AT, Tong ER, Palanki R, Hall ML, Bedingfield SK, Mitchell MJ. High-Throughput In Vivo Screening Identifies Structural Factors Driving mRNA Lipid Nanoparticle Delivery to the Brain. ACS Nano. 2026 Feb 03; 20(4):3807-3820.
-
Lindsey ML, Chen EI, Shivam P, Nde PN, Horn D, Renuse S, Hakimi A, Baxter BT, Terrin M, Matsumura JS, Gaye A, Curci JA. Comprehensive evaluation of plasma biomarkers in patients with abdominal aortic aneurysm using high-throughput, label-free quantitative proteomic profiling. Am J Physiol Heart Circ Physiol. 2026 Feb 01; 330(2):H000.
-
Yoo S, Han EL, Murray AM, Kim D, Bang EK, Mitchell MJ. High-Throughput Formulation Using Fast mRNA Lipid Nanoparticle Assembly via Simple Thermomixing (HTF-FLASH). Nano Lett. 2025 10 08; 25(40):14695-14703.
-
Ouyang WO, Lv H, Liu W, Lei R, Mou Z, Pholcharee T, Talmage L, Tong M, Ji W, Wang Y, Dailey KE, Gopal AB, Choi D, Ardagh MR, Rodriguez LA, Guthmiller JJ, Dai X, Wu NC. High-throughput synthesis and specificity characterization of natively paired influenza hemagglutinin antibodies with oPool+ display. Sci Transl Med. 2025 Sep 03; 17(814):eadt4147.
-
Liu S, Li L, Zhang F, Garcia-Corral M, Meyer K, Fortuna PRJ, van Sambeek B, Appleton E, Ng AHM, Khoshakhlagh P, Lu YR, Cameron J, Ramirez RN, Chen Y, Wu CT, Huang JY, Tan Y, Chao G, Aach J, Lim ET, Tam JM, Raychaudhuri S, Church GM. Iterative transcription factor screening enables rapid generation of microglia-like cells from human iPSC. Nat Commun. 2025 Jun 10; 16(1):5136.
-
Khang A, Barmore A, Tseropoulos G, Bera K, Batan D, Anseth KS. Automated prediction of fibroblast phenotypes using mathematical descriptors of cellular features. Nat Commun. 2025 Mar 22; 16(1):2841.
-
Smith CF, Baldé MA, French S, Modahl CM, Bahrabadi L, Amponsah-Asamoah M, Larson KY, Maroney SP, Galindo DC, Millimouno M, Camara N, Benjamin J, Brandehoff NP, McCabe MC, Cohen MJ, Jackson K, Baldé C, Castoe TA, Mackessy SP, Hansen KC, Saviola AJ. Discerning specific thrombolytic activities and blood clot degradomes of diverse snake venoms with untargeted peptidomics. J Thromb Haemost. 2025 Jul; 23(7):2198-2212.
-
Buitrago L, Menezes MR, Larson C, Li J, Kartika T, Banerjee P, Glickman F, Coller B. Unbiased high-throughput screening of drug-repurposing libraries identifies small-molecule inhibitors of clot retraction. Blood Adv. 2025 Mar 11; 9(5):1049-1068.
-
Bisirri EA, Kaar JL, Schwartz DK. High-Throughput Screening Identifies Anionic Polymer Supports that Improve Enzyme Activity at Low pH and High Temperature. Langmuir. 2025 Mar 04; 41(8):5335-5346.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|